Herbochem Unveils Groundbreaking Research on Ashwagandha’s Impact on Mental Health
Herbochem, a trailblazer in herbal and natural products with over 50 years of industry prowess, proudly announced a breakthrough study on the mental health benefits of Ashwagandha. This significant study, published in the International Journal of Research in Medical Sciences, highlights the efficacy of Ashwagandha. As an ancient medicinal herb deeply rooted in traditional Ayurvedic practices, Ashwagandha (Withania somnifera) has been a cornerstone of holistic well-being in India for centuries. Recognized as an adaptogen, it plays a vital role in stress management and overall balance within the body. The research underscores the adaptogenic, anti-stress, anti-anxiety, and antidepressant properties of Ashwagandha. With mental health disorders on the rise globally, particularly during the COVID-19 pandemic, Ashwagandha emerges as a potent solution to alleviate symptoms such as depression, stress, anxiety, and sleep disorders.
In a head-to-head comparison, the study zeroes in on two Ashwagandha brands: Herbochem +91 (500mg capsules) and 600mg capsules from another notable brand. Renowned for its adaptogenic and antidepressant properties, Ashwagandha showcased remarkable efficacy in mitigating mental health symptoms. The research revealed compelling insights into the efficacy and safety of Ashwagandha 500mg capsules. Ashwagandha 500mg exhibited significantly higher reductions in perceived stress, Hamilton depression scale scores, and Beck’s anxiety inventory scores when compared to the control group. The study establishes that the optimal dosage of Ashwagandha 500mg demonstrated superior efficacy in reducing mental health symptoms compared to the Ashwagandha 600mg.
The study, a collaborative effort by renowned institutions including the Department of Biochemistry at Shivaji University, Kolhapur, Maharashtra, ViVforever Aesthetics Private Limited, Mumbai, Maharashtra, and the Critical Care Department at Vakratunda Hospital, Nashik, Maharashtra, delves into the global surge in mental health disorders, particularly during the COVID-19 pandemic. The study emphasizes the prevalent symptoms of depression, stress, anxiety, and sleep disorders, underscoring the pressing need for effective solutions.
Mr. Karthik Kondepudi, Partner at Herbochem, stated, “This study reaffirms Herbochem’s dedication to providing innovative, effective, and safe solutions that contribute to a healthier world. At Herbochem, our commitment extends beyond manufacturing. We are devoted to crafting products that not only meet the highest standards of quality but also make a meaningful impact on the well-being of individuals.
Herbochem’s +91 Ashwagandha stands as a paragon of Ayurveda’s holistic health approach. This full-spectrum standardized extract, unique in its extraction technique, not only captures active compounds but also maximizes vital macro-nutrients like Potassium and Magnesium. These elements play a crucial role in stress reduction and promoting better sleep, making +91 Ashwagandha® a distinctive and comprehensive solution for holistic well-being.